CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 51 enrolled
Drug / intervention
d-cycloserine +1 moredrug
Likely dose
d-cycloserine 250 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01361633
NCT01361633Phase 2Completed
CompareCT.gov

The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly

Hartford Hospital·interventional·Posted May 27, 2011·Updated Feb 18, 2021

In Brief

A Phase 2 clinical trial evaluating d-cycloserine and Sugar Pill for Treatment and Placebo. Completed, enrolled 51 participants across 1 site.

Detailed Summary

The goal of this study is to determine whether a study medication (d-cycloserine) improves the ability of older adults to perform on tests of neuropsychological functioning. Tests of neuropsychological functioning assess attention, memory, and executive functioning skills (for example, problem-solving, planning and organizing skills). It was hypothesized that participants who received study medication would perform better on neuropsychological tests than would participants who received the sugar pill.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTreatment, Placebo
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 27, 2011
Enrollment StartJan 1, 2008
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 15.1 years ago

Interventions

d-cycloserinedrug

single oral administration of 250 mg d-cycloserine

Sugar Pilldrug

Single oral administration 250 mg Sugar Pill